Chest
Volume 130, Issue 1, July 2006, Pages 176-181
Journal home page for Chest

Original Research
Reduced Exercise Capacity and Stress-Induced Pulmonary Hypertension in Patients With Scleroderma

https://doi.org/10.1378/chest.130.1.176Get rights and content

Objectives

We sought to determine the incidence of stress-induced pulmonary artery (PA) systolic hypertension in a referral population of patients with scleroderma, and to examine the relation between stress-induced pulmonary systolic hypertension and exercise capacity in this population.

Background

Early detection of patients with scleroderma at risk for pulmonary hypertension (PHTN) could lead to more timely intervention and thus reduce morbidity and improve mortality. The change in PA systolic pressure (PASP) with exercise provides a possible tool for such detection.

Methods

Sixty-five patients with scleroderma (9 men and 56 women; mean age 51 ± 12 years [SD]), normal resting PASP, and normal resting left ventricular function underwent exercise Doppler echocardiography using a standard Bruce protocol. Tricuspid regurgitation velocity was measured before and after exercise. Exercise variables including workload achieved in metabolic equivalents (METS), total exercise time, percentage of target heart rate achieved, and PASP at rest and within 60 s after exercise were recorded.

Results

Thirty patients (46%) demonstrated an increase in PASP to > 35 mm Hg plus an estimated right atrial pressure of 5 mm Hg. Postexercise PASP inversely correlated to both the maximum workload achieved (r = − 0.34, p = 0.006) and exercise time (r = − 0.31, p = 0.01). In women, the correlation was more significant (r = − 0.38, p = 0.003). Patients in the lowest quartile of exercise time, with the least cardiac workload achieved, produced the highest postexercise PASP.

Conclusion

Stress-induced PHTN is common in patients with scleroderma, even when resting PASP is normal. Stress Doppler echocardiography identifies scleroderma patients with an abnormal rise in PASP during exertion. Peak PASP is linearly related to exercise time and maximum workload achieved. Measurement of PASP during exercise may prove to be a useful tool for the identification of future resting PHTN.

Section snippets

Patients

The study included consecutive patients from February 2003 to April 2004 18 years old with a rheumatologist-established diagnosis of scleroderma by standard criteria.15 Patients were referred as part of their routine follow-up care. Both, patients with diffuse systemic sclerosis or limited scleroderma (CREST syndrome [calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia]) were accepted. PASP was normal or only mildly elevated at rest (PASP ≤ 35 mm Hg plus

Results

All patients had normal wall motion at baseline. There were no clinical signs of heart failure on physical examination. The vast majority of patients had no left ventricular hypertrophy. Diabetes (n = 1) and hypertension (n = 6) were infrequent. Resting diastolic function was normal (Table 1). Pulmonary function data were available for 57 patients (87%; Table 1). Right atrial pressure was estimated at 5 mm Hg for all patients. No patients complained of exertional chest pain. Thirty patients

Discussion

In this study, we demonstrate that stress-induced pulmonary systolic hypertension in patients with scleroderma is highly prevalent, and is associated with reduced exercise capacity, decreased maximum cardiac workload, and decreased adjusted Dlco. While our data do not directly examine the mechanism underlying these relations, they do suggest that determinants of exercise capacity in scleroderma patients may vary from those variables that govern more traditional populations undergoing exercise

Acknowledgment

The authors thank Dr. Irfan Yusufzai for his assistance in data collection and management.

References (26)

  • RaesideDA et al.

    Ambulatory pulmonary artery pressure monitoring during sleep and exercise in normal individuals and patients with COPD

    Thorax

    (2002)
  • PalevskyHI

    Exercise and the pulmonary circulation

    (1986)
  • BevegardS et al.

    Circulatory studies in well trained athletes at rest and during heavy exercise, with special reference to stroke volume and the influence of body position

    Acta Physiol Scand

    (1963)
  • Cited by (104)

    • Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary circulation in patients with systemic sclerosis

      2019, Advances in Medical Sciences
      Citation Excerpt :

      SSc patients often experience dyspnea with exercise. Alkotob et al. [19] and Mininni et al. [20] revealed that exercise-induced increases in TRPG on echocardiogram commonly occur in SSc, but RHC was not performed to confirm these findings. Steen et al. [12] evaluated 54 SSc patients and revealed an increase in exercise TRPG > 20 mmHg in 44% of them.

    • Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis: A Clinical Challenge for Cardiologists and Rheumatologists

      2018, Heart Failure Clinics
      Citation Excerpt :

      Exercise echocardiography is a noninvasive tool to estimate pulmonary hemodynamics during exercise and is useful to assess abnormalities of pulmonary vascular function as well as the state of the right heart, although it does not have an established role in the management of SSc patients. A main issue in SSc is the high percentage of patients showing exercise PH during exercise stress echocardiography, which clearly overestimates the subset of SSc patients who will develop PAH.63–66 PAP is dependent, however, not only on PVR, which is abnormally increased in PAH, but also on left atrial pressure and CO, as shown both in healthy subjects67 and in SSc.51

    • Stressing the Cardiopulmonary Vascular System: The Role of Echocardiography

      2018, Journal of the American Society of Echocardiography
    View all citing articles on Scopus

    Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml).

    Supported in part by National Institutes of Health General Clinical Research Center grant MO1RR06192.

    There are no conflicts of interest or financial disclosures for any of the authors.

    View full text